Minerva Neurosciences | Zysk Brutto

Cena Akcji
6.27
Dzienna Zmiana
-0.04 -0.63%
Miesięcznie
45.14%
Rocznie
219.90%
Q1 Prognozy TE
2.46




Zysk Brutto Zmiana Data
Acadia Pharmaceuticals USD 44.6M 4.38M 2025-09
Adma Biologics USD 47.52M 7.42M 2025-09
ALKERMES USD 100.74M 4.1M 2025-09
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
AstraZeneca USD 3.24B 117M 2025-09
BioCryst Pharmaceuticals USD -86.95M 73.5M 2024-12
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Cipla INR 11.69B 6.85B 2025-12
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -6.94M 421K 2025-09
CSL USD 1.4B 1.14B 2025-06
Dynavax Technologies USD 28.42M 7.2M 2025-09
Eli Lilly USD 7.23B 456M 2025-09
Esperion Therapeutics USD 67.66M 3.6M 2024-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Grifols EUR 66.98M 19.92M 2024-06
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Ionis Pharmaceuticals USD -129M 253M 2025-09
J&J USD 4.97B 2.53B 2025-12
Merck USD 6.74B 22M 2025-09
Minerva Neurosciences USD 22.51M 30.74M 2024-09
Neurocrine Biosciences USD 291.8M 132.3M 2025-09
Novartis USD 4.2B 335M 2025-09
Novavax USD -122.33M 286.92M 2024-09
Pfizer USD 3.33B 290M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Takeda JPY 133.86B 105.69B 2025-12
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12


Minerva Neurosciences Zysk Brutto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.